Mainstream

UroGen Pharma GAAP EPS of -$0.92 misses by $0.14, revenue of $20.3M misses by $2.4M

UroGen Pharma GAAP EPS of -$0.92 misses by $0.14, revenue of $20.3M misses by $2.4M

Post ContenturgnRead More

You might also be interested in reading Sandfire Resources boosts copper production guidance for FY26 with strong operational performance.

May 12, 2025
In Mainstream